🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Dutasteride Capsules

Found 38 matching trials

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State

PHASE1

The purpose of this study is to assess the bioequivalence of the second gen...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-02-11

Trial ID

NCT02058576

Treatments Being Tested

Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule

To Evaluate the Pharmacokinetics and Safety of AD-208

PHASE1

To evaluate pharmacokinetics and safety of AD-208....

Status

Completed

Location

Kyungpook National University Hospital

Start Date

2020-01-03

Trial ID

NCT04214808

Treatments Being Tested

AD-208 Avodart Soft Capsule 0.5mg

Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

PHASE3

The purpose of this study is to assess the safety and efficacy of the DTT10...

Status

Not Yet Recruiting

Location

EMS

Start Date

2025-02

Trial ID

NCT06264414

Treatments Being Tested

DTT106 Dutasteride-Tamsulosin

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

PHASE1

This study is an open-label, randomized, single dose, multi-stage, cross-ov...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-11-06

Trial ID

NCT01495026

Treatments Being Tested

Dutasteride (0.5mg, fasted state)Dutasteride (0.5mg, fed state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fed state)Harnal-D Tablets with water (fasted state)Harnal-D Tablets with water (fed state)Harnal-D tablets without water (fasted state)

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia

PHASE3

This is a multicentre, randomised, double-blind, parallel group study in As...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-02-10

Trial ID

NCT02058368

Treatments Being Tested

Dutasteride 0.5mg capsules Dutasteride placebo capsules Tamsulosin 0.2mg tablets Disintegrating placebo tamsulosin tablet

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

PHASE3

Treatment of male pattern hair loss (MPHL) or androgenetic alopecia (AGA) w...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-07-02

Trial ID

NCT02014584

Treatments Being Tested

Dutasteride Placebo

Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers

PHASE1

The aim of this study is to determine the bioequivalence of 5 x 0.1 milligr...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-09-23

Trial ID

NCT01929330

Treatments Being Tested

GI198745 0.1 mg GI198745 0.5 mg

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

PHASE3

This randomized, double-blind, placebo-controlled, six-month parallel-group...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-10

Trial ID

NCT00527605

Treatments Being Tested

Dutasteride 0.5mg capsule Dutasteride matched placebo

Drug Use Investigation for AVOLVE(BPH)

N/A

The study is designed to investigate the safety and efficacy of dutasteride...

Status

Completed

Location

Multiple Locations

Start Date

2010-12

Trial ID

NCT01376284

Treatments Being Tested

Dutasteride

Dutasteride for the Reduction of Alcohol Use in Male Drinkers

PHASE4

The purpose of this study is to evaluate whether dutasteride is safe and ef...

Status

Completed

Location

University of Connecticut Health Center

Start Date

2011-01

Trial ID

NCT01262287

Treatments Being Tested

Dutasteride Placebo

Previous Next